Sondra H. Berger

1.1k total citations
35 papers, 914 citations indexed

About

Sondra H. Berger is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sondra H. Berger has authored 35 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 25 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Sondra H. Berger's work include Biochemical and Molecular Research (27 papers), Colorectal Cancer Treatments and Studies (24 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Sondra H. Berger is often cited by papers focused on Biochemical and Molecular Research (27 papers), Colorectal Cancer Treatments and Studies (24 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Sondra H. Berger collaborates with scholars based in United States, Jordan and Egypt. Sondra H. Berger's co-authors include François Berger, Lukasz Lebioda, Karen W. Barbour, Michael D. Wyatt, R. Bruce Dunlap, Maire Hakala, Lee F. Johnson, Chung‐Her Jenh, Jason Phan and W. Minor and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Sondra H. Berger

35 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sondra H. Berger United States 16 638 550 175 127 120 35 914
Donna Voeller United States 20 827 1.3× 559 1.0× 58 0.3× 61 0.5× 97 0.8× 40 1.3k
R G Moran United States 18 878 1.4× 352 0.6× 68 0.4× 369 2.9× 55 0.5× 28 1.3k
Virginie Moucadel France 17 422 0.7× 194 0.4× 128 0.7× 24 0.2× 67 0.6× 26 934
Y M Rustum United States 17 435 0.7× 509 0.9× 20 0.1× 44 0.3× 78 0.7× 29 900
Lynn S. Gossett United States 10 475 0.7× 381 0.7× 34 0.2× 142 1.1× 35 0.3× 13 943
J.R. Bertino United States 16 462 0.7× 221 0.4× 29 0.2× 175 1.4× 53 0.4× 28 925
Mark Sales United Kingdom 13 300 0.5× 131 0.2× 93 0.5× 38 0.3× 117 1.0× 15 608
Troii Hall United States 14 625 1.0× 207 0.4× 30 0.2× 65 0.5× 28 0.2× 24 943
Brigitte Schott Switzerland 12 532 0.8× 447 0.8× 21 0.1× 31 0.2× 24 0.2× 14 876
David Blake United States 12 489 0.8× 348 0.6× 30 0.2× 31 0.2× 56 0.5× 33 843

Countries citing papers authored by Sondra H. Berger

Since Specialization
Citations

This map shows the geographic impact of Sondra H. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sondra H. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sondra H. Berger more than expected).

Fields of papers citing papers by Sondra H. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sondra H. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sondra H. Berger. The network helps show where Sondra H. Berger may publish in the future.

Co-authorship network of co-authors of Sondra H. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Sondra H. Berger. A scholar is included among the top collaborators of Sondra H. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sondra H. Berger. Sondra H. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Mesallamy, Hala O., Hekmat M. El Magdoub, James Chapman, et al.. (2018). Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach. PLoS ONE. 13(3). e0193810–e0193810. 8 indexed citations
2.
Yousef, Al‐Motassem, Maha Shomaf, Ismail Said, et al.. (2015). Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study. Asian Pacific Journal of Cancer Prevention. 16(8). 3101–3109. 10 indexed citations
3.
Yousef, Al‐Motassem, et al.. (2013). Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Colorectal Cancer among Jordanian Population. Asian Pacific Journal of Cancer Prevention. 14(8). 4559–4565. 13 indexed citations
4.
Lebioda, Lukasz, et al.. (2011). Evolution of Metamorphism in Thymidylate Synthases Within the Primate Lineages. Journal of Molecular Evolution. 72(3). 306–314. 4 indexed citations
5.
Huang, Xiao, L.L. Lovelace, Maria Marjorette O. Peña, et al.. (2010). Replacement of Val3 in Human Thymidylate Synthase Affects Its Kinetic Properties and Intracellular Stability,. Biochemistry. 49(11). 2475–2482. 14 indexed citations
6.
7.
Lovelace, L.L., et al.. (2009). Variants of human thymidylate synthase with loop 181–197 stabilized in the inactive conformation. Protein Science. 18(8). 1628–1636. 15 indexed citations
8.
Berger, Sondra H., Douglas L. Pittman, & Michael D. Wyatt. (2008). Uracil in DNA: Consequences for carcinogenesis and chemotherapy. Biochemical Pharmacology. 76(6). 697–706. 63 indexed citations
9.
You, Shaojin, Maria Marjorette O. Peña, Lucy Liu, et al.. (2006). Developmental abnormalities in multiple proliferative tissues of ApcMin/+ mice. International Journal of Experimental Pathology. 87(3). 227–236. 43 indexed citations
10.
You, Shaojin, et al.. (2005). Possible role of APC gene in hematopoisis: An implication from anemia in ApcMIN/+ mice. Cancer Research. 65. 463–463. 1 indexed citations
11.
Berger, Sondra H., Franklin G. Berger, & Lukasz Lebioda. (2003). Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthase. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1696(1). 15–22. 37 indexed citations
12.
Steadman, David, H. Trent Spencer, R. Bruce Dunlap, & Sondra H. Berger. (1999). Substitution at Residue 214 of Human Thymidylate Synthase Alters Nucleotide Binding and Isomerization of Ligand−Protein Complexes. Biochemistry. 38(17). 5582–5587. 7 indexed citations
13.
14.
Hoganson, Diana K., et al.. (1999). Isolation and characterization of a thymidylate synthase-deficient human colon tumor cell line. Biochemical Pharmacology. 58(10). 1529–1537. 11 indexed citations
15.
Barbour, Karen W., et al.. (1993). Genetic Variation in Thymidylate Synthase Confers Resistance to 5-Fluorodeoxyuridine. Advances in experimental medicine and biology. 339. 67–76. 2 indexed citations
16.
Barbour, Karen W., Diana K. Hoganson, Sondra H. Berger, & François Berger. (1992). A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.. Molecular Pharmacology. 42(2). 242–248. 25 indexed citations
17.
Barbour, Karen W., et al.. (1990). Single amino acid substitution defines a naturally occurring genetic variant of human thymidylate synthase.. Molecular Pharmacology. 37(4). 515–518. 32 indexed citations
18.
Berger, Sondra H., Stephen T. Davis, Karen W. Barbour, & Franklin G. Berger. (1988). The Role of Thymidylate Synthase in the Response to Fluoropyrimidine-Folinic Acid Combinations. Advances in experimental medicine and biology. 244. 59–69. 5 indexed citations
19.
Barbour, Karen W., Sondra H. Berger, Franklin G. Berger, & E. Aubrey Thompson. (1988). Glucocorticoid Regulation of the Genes Encoding Thymidine Kinase, Thymidylate Synthase, and Ornithine Decarboxylase in P1798 Cells. Molecular Endocrinology. 2(1). 78–84. 18 indexed citations
20.
Berger, Sondra H. & Maire Hakala. (1984). Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.. Molecular Pharmacology. 25(2). 303–309. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donna Voeller Breakdown of academic impact, for papers by R G Moran Breakdown of academic impact, for papers by Virginie Moucadel Breakdown of academic impact, for papers by Y M Rustum Breakdown of academic impact, for papers by Lynn S. Gossett Breakdown of academic impact, for papers by J.R. Bertino Breakdown of academic impact, for papers by Mark Sales Breakdown of academic impact, for papers by Troii Hall Breakdown of academic impact, for papers by Brigitte Schott Breakdown of academic impact, for papers by David Blake
Rankless by CCL
2026